Each tumor has its own unique features and contains a combination of genetic abnormalities that determine its aggressiveness and response to treatment. And it is the knowledge and understanding of these anomalies that enables the doctor to determine the treatment tactics.
How does it work?
Since 2021, the CSD LAB medical laboratory has been providing cancer diagnostics based on the unique NGS (next-generation sequencing) technology from the leading manufacturer Illumina. This technology allows you to completely and accurately identify genetic abnormalities within a single test and is the gold standard in the field of oncology.
Special offer in May.
We want to make these latest technologies available to every Ukrainian, so we are reducing prices for the most popular NGS panels in May:
-MyGene BRCA1/2 (NGS, hereditary mutation screening, blood, Illumina) / N – 9,800 UAH instead of 11,500 UAH;
-MyGene HRR (NGS panel of hereditary mutations in 32 genes for ovarian, prostate, breast and pancreatic cancer, blood, Illumina) / N – UAH 11,610 instead of UAH 12,900;
-MyAction BRCA1/2 (NGS, full spectrum of mutations, histological material, Illumina) / N – 7 11 900 UAH instead of 13 500.
Validity period: 01.05.2023 to 31.05.2023
Details of the promotion on the website
